Combination of paclitaxel with eugenol effectively enhances anticancer characteristics of paclitaxel on the A549 lung cancer cell line
{{output}}
Lung cancer, primarily non-small cell lung cancer (NSCLC), is a leading global cause of cancer mortality, driven by late diagnosis, drug resistance, and chemotherapy toxicity. Paclitaxel, a standard agent, stabilizes microtubules to induce G2/M arrest and apop... ...
